LANXESS worldwide

Corporate Website en | de

Asia

  • Australia en

  • China cn | en

  • India en

  • Indonesia en

  • Japan jp

  • Korea kr

  • Malaysia en

  • Pakistan en

  • Philippines en

  • Singapore

  • Thailand en

  • Vietnam en

EMEA

  • Austria en

  • Belgium nl

  • Czech en

  • France fr

  • Hungary en

  • Italy en

  • Netherlands en

  • Poland en

  • Russia en

  • Serbia en

  • Slovakia en

  • Spain en

  • Turkey en

  • United Arab Emirates en

  • United Kingdom en

Americas

Contact

LANXESS Canada Contacts

Contact our Sites in Canada

 

Media Inquiries

Global Press Releases

2017-08-10

LANXESS continues to expect record earnings for 2017 following strong second quarter

  • Sales up almost 30 percent to EUR 2.5 billion
  • EBITDA pre exceptionals increased significantly by 25.3 percent to EUR 367 million
  • EBITDA margin pre exceptionals at 14.6 percent
  • Chemtura acquisition delivers significant earnings contribution
  • Reporting in new segment structure
  • Net income pre exceptionals increased by 75 percent to EUR 141 million
  • Guidance for the full year 2017 confirmed: EBITDA pre exceptionals between EUR 1.225 billion and EUR 1.3 billion

Following a good second quarter 2017, specialty chemicals company LANXESS continues to expect the highest earnings in the company’s history for the current financial year.

Global sales of the company increased by almost 30 percent to EUR 2.5 billion, up from EUR 1.9 billion a year earlier. EBITDA pre exceptionals improved by around 25 percent to EUR 367 million, compared with EUR 293 million in the prior-year quarter. This increase was primarily due to the earnings contribution from the newly acquired Chemtura businesses as well as to higher volumes and selling prices. The EBITDA margin pre exceptionals in the second quarter of 2017 stood at 14.6 percent, which was slightly below the high value of 15.1 percent reported in the prior-year period.

“Our growth strategy is paying off. Our strong operating performance and our profitable acquisitions are the basis for our strong results in the second quarter. The newly acquired Chemtura businesses are already making a significant earnings contribution, and the other areas of our speciality chemicals portfolio are also developing positively,” said LANXESS CEO Matthias Zachert.

Due to one-time exceptional charges, net income was EUR 3 million, after EUR 75 million in the prior-year quarter. The one-time effects resulted from the Chemtura acquisition and the planned closure of chrome chemicals production at the Zárate site in Argentina in the fourth quarter of 2017. Adjusted for these effects, net income increased by around 75 percent to EUR 141 million, compared with EUR 80 million in the second quarter of 2016.

“We are overall well on track and continue to expect record earnings for the full year. However, compared with the very strong prior year, we are anticipating a slightly weakened momentum for the second half of 2017,” said Zachert.

LANXESS continues to forecast EBITDA pre exceptionals for the full year 2017 of between EUR 1.225 billion and EUR 1.3 billion. The company achieved its highest operating result to date in 2012, when it posted a figure of around EUR 1.2 billion.

Reporting in new segment structure

At the end of April, LANXESS completed the acquisition of U.S. chemical company Chemtura and subsequently adjusted its Group structure. With immediate effect, LANXESS is reporting on five segments comprising a total of twelve business units.

The Advanced Intermediates segment covers the intermediates and agrochemicals businesses. The new Specialty Additives segment bundles additives activities. The Performance Chemicals segment is made up of the business units responsible for color pigments, leather chemicals, material protection products and water treatment technologies. The Engineering Materials segment comprises the businesses for high-performance plastics and urethanes. The ARLANXEO segment encompasses the synthetic rubbers business. In segment reporting, prior-year figures were restated where necessary.

Sales substantially higher year on year across all segments

Sales of the Advanced Intermediates segment in the second quarter of 2017 were EUR 505 million, 14.0 percent above the prior-year figure of EUR 443 million. EBITDA pre exceptionals increased by 10.2 percent to EUR 97 million, compared with EUR 88 million a year earlier. Positive effects came especially from higher selling prices and the contribution from the new Organometallics business unit. The EBITDA margin pre exceptionals was 19.2 percent, against 19.9 percent in the prior-year quarter.

Sales in the new Specialty Additives segment climbed by 106.6 percent to EUR 440 million, compared with EUR 213 million a year earlier. EBITDA pre exceptionals advanced by 67 percent to EUR 75 million, compared with the prior-year level of EUR 45 million. This positive development was primarily due to the contribution from the newly acquired Chemtura businesses. Higher volumes also supported this effect. The EBITDA margin pre exceptionals of 17.0 percent was below the high level of 21.1 percent reported in the prior-year quarter.

Sales in the Performance Chemicals segment rose by 11.2 percent in the second quarter of 2017, to EUR 367 million, against EUR 330 million a year earlier. EBITDA pre exceptionals advanced by 15.9 percent to EUR 80 million, compared with the prior-year level of EUR 69 million. Higher selling prices and the Clean and Disinfect specialties business acquired in 2016 had a positive effect on earnings. The EBITDA margin pre exceptionals increased from 20.9 percent to 21.8 percent.

In the new Engineering Materials segment, sales increased by 31.3 percent to EUR 361 million, up from EUR 275 million a year earlier. EBITDA pre exceptionals increased by a substantial 60.0 percent, from EUR 45 million to EUR 72 million. The newly acquired urethanes business from Chemtura made a particular contribution to improved earnings. Higher volumes, higher selling prices and very good capacity utilization also contributed to the positive development of earnings. The resulting EBITDA margin pre exceptionals of 19.9 percent was significantly above the figure of 16.4 percent posted in the prior-year quarter.

Sales in the ARLANXEO segment climbed by 24.6 percent to EUR 835 million, compared with EUR 670 million a year earlier. EBITDA pre exceptionals decreased by 3.0 percent to EUR 92 million, compared with EUR 95 million a year earlier. Higher energy costs in particular stood against the success in passing on increased raw material costs. The EBITDA margin pre exceptionals was 11.0 percent, against 14.2 percent a year earlier.

Q2 2017 Key Data

(figures in EUR million)

 

 

Q2 2016

 
 

Q2 2017

 
 

Change in percent

 
 

Sales

 
 

1,943

 
 

2,522

 
 

30

 
 

EBITDA pre exceptionals

 
 

293

 
 

367

 
 

25

 
 

EBITDA margin pre exceptionals (percent)

 
 

15.1

 
 

14.6

 
 

 

 
 

Net income

 
 

75

 
 

3

 
 

(96)

 
 

Earnings per share (€)

 
 

0.82

 
 

0.04

 
 

(96)

 
 

Earnings per share pre exceptionals (€)

 
 

0.88

 
 

1.54

 
 

75

 



Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.

LANXESS is a leading specialty chemicals company with sales of EUR 7.7 billion in 2016 and about 19,200 employees in 25 countries. The company is currently represented at 75 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World) and FTSE4Good.

Contact

Ingo Drechsler

Ingo Drechsler
Head of External Relations

Phone: +49 221 888 53790

Fax: +49 221 8885 4994

send E-Mail

Alexander Böhm

Alexander Böhm
Spokesperson Financial and Business Media

Phone: +49 221 8885 4746

send E-Mail

Link

Download